Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
May 20th, 2019
Intratracheal (IT) administration of experimental agents in mice often results in asymmetric delivery to the distal lungs. In this report, we describe a direct intrabronchial (IB) approach to cannulate each lung in living mice non-operatively. This approach can be used to selectively administer agents to one lung or may be adapted to improve the symmetric agent delivery to both lungs.
Overview
This study presents a direct intrabronchial approach for administering experimental agents to the lungs of living mice. This method allows for selective delivery to one lung or can be adapted for more symmetric distribution across both lungs.
Key Study Components
Area of Science
- Neuroscience
- Respiratory Physiology
- Experimental Techniques
Background
- Intratracheal administration often leads to uneven agent distribution in the lungs.
- Targeting individual lungs can enhance the study of lung diseases.
- Proper catheter preparation is crucial for successful administration.
- Practice is necessary to master this technique.
Purpose of Study
- To develop a method for unilateral lung administration of agents.
- To improve the symmetry of agent delivery to both lungs.
- To provide a non-operative technique for lung cannulation in mice.
Methods Used
- Intrabronchial cannulation in anesthetized mice.
- Preparation of catheters including polishing and angulation.
- Modification of the technique for bilateral administration.
- Practice sessions to enhance technique proficiency.
Main Results
- Successful unilateral administration of agents to individual lungs.
- Potential for improved symmetric delivery across both lungs.
- Demonstrated effectiveness of catheter preparation techniques.
- Highlighted the importance of practice in mastering the method.
Conclusions
- The intrabronchial approach is a viable alternative to intratracheal administration.
- This method can enhance research on lung diseases by allowing targeted delivery.
- Further studies may refine this technique for broader applications.
Frequently Asked Questions
Executive Industry Relevance
Selective intrabronchial administration in murine models addresses a critical challenge in preclinical respiratory research by enabling precise agent deposition within targeted lung regions. This technique enhances the predictive confidence of disease modeling and therapeutic evaluation by reducing delivery asymmetry and improving experimental control. Its adoption supports more reliable translational insights for portfolio decisions in pulmonary drug discovery.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of lung-specific therapeutic hypotheses by targeting individual lobes or lungs.
- Improves biological de-risking by minimizing confounding effects of asymmetric agent distribution.
- Supports functional target validation through controlled regional delivery in disease models.
Screening & Assay Development
- Facilitates preparation of validated murine models with reproducible agent exposure profiles.
- Enhances assay standardization by enabling dose-adjusted, symmetric delivery across lungs.
- Improves screening readiness for evaluating compound effects in defined pulmonary compartments.
Translational & Preclinical Research
- Aligns preclinical models with disease-relevant agent distribution, supporting translational biomarker studies.
- Provides continuity from discovery to preclinical validation by refining injury and response localization.
- Reduces risk of misleading outcomes due to delivery heterogeneity in lung injury models.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum by enabling precise agent administration for hypothesis testing, model validation, and translational research in pulmonary disease.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating lung-specific responses.
- Screening: Delivers reproducible, quantitative outputs for comparing agent effects across lung regions.
- Analytics: Provides measurable readouts of agent deposition and injury localization for robust statistical analysis.
- Translational Research: Enhances alignment with clinical disease patterns by modeling region-specific injury and repair.
- Enterprise Reuse: Establishes a reusable platform for diverse pulmonary agent evaluation in murine models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in lung disease models.
- Operational Value: Standardizes agent delivery, improving reproducibility and scalability across studies.
- Strategic Value: Enables better go/no-go decisions by clarifying agent effects and reducing late-stage biological risk.
- Portfolio Impact: Supports risk-adjusted prioritization of respiratory candidates based on robust preclinical data.
Implementation Considerations
- Requires technical expertise in murine anesthesia and bronchial cannulation.
- Needs specialized catheter preparation and positioning equipment for precise delivery.
- Demands cross-team standardization to ensure reproducibility of agent deposition.
- May require adaptation for different mouse strains or lung sizes.
- Persistent intra-lobar heterogeneity may limit uniformity despite dose adjustment.
Biopharma FAQs
Chapters in this video
0:04
Title
1:09
Non-Operative Intratracheal (IT) Intubation
2:16
Intrabronchial (IB) Approach to Distal Right Lung Selective Lobar Cannulation
3:00
IB Approach to Distal Left Lung Selective Segmental Cannulation
3:44
Right Entire Lung Administration
4:37
Left Entire Lung Administration
5:31
Results: Representative Effects of Direct IB Selective Agent Administration to Whole Mouse Lung
6:49
Conclusion
